# Therapy to Prevent Sexual Pain in Breast Cancer Survivors

> **NCT01539317** · PHASE3 · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 50 (actual)

## Conditions studied

- Vulvodynia
- Dyspareunia
- Breast Cancer
- Menopause

## Interventions

- **DRUG:** Topical liquid lidocaine
- **DRUG:** Topical saline

## Key facts

- **NCT ID:** NCT01539317
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539317, "Therapy to Prevent Sexual Pain in Breast Cancer Survivors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01539317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*